Navigation Links
ACN - 2

ProductsACN - 2
Company GYRUS ACMI
Item ACN - 2
Features 
  • Small outer diameter > Easy insertion, designed for patient comfort
  • AutoSeal > No vent valve needed for soak disinfection/gas sterilization
  • Beveled 14.6 Fr (4.8 mm) distal tip, with UltraGlide? cover > Less traumatic insertion
  • Tight bend radius > Ease of examination of the entire bladder
  • Rotatable light post and biopsy port > Maximum convenience for left- or right-handed use
  • Logical deflection, 180 up, 170 down > Panoramic view = 350
  • Description The ACMI USA Series ACN-2 Flexible CystoNephroscope is used for percutaneous and transurethral procedures. It is ideal for office practice. The large 6.4 Fr (2.1 mm) working channel accommodates a full range of operating instruments for therapeutic applications. The flexible shaft, small outer diameter, and beveled, UltraGlide covered tip provide fast, less traumatic access and increased patient comfort. The unique rotating light post, biopsy/irrigating ports, and integrated diopter correction ensure operator convenience and reduced procedure times. The ACN-2 incorporates an AutoSeal feature which allows for both EO gas sterilization or soak disinfection, without a vent valve.
    Info GYRUS ACMI
    Customer Service: (508) 804-2600
    Web site: http://www.acmicorp.com

    Related medicine products :

    1. Webster Small Anatomy Deflectable Catheters
    2. Webster Coronary Sinus Deflectable Catheters
    3. Webster Quadripolar Standard Deflectable Catheters
    4. Webster Octapolar Standard Deflectable Catheters
    5. Webster Quadrapolar Standard Deflectable Catheters
    6. Webster Decapolar Standard Deflectable Catheters
    7. Webster Decapolar Coronary Sinus Deflectable Catheters
    8. Webster Hexapolar Standard Deflectable Catheters
    9. Webster Crista Cath 20-Pole Deflectable Catheter
    10. Webster Ismus Cath 20-Pole Deflectable Catheter
    11. Halo XP 20 Pole Deflectable Catheter
    For the quantitative in vitro determination of Total Protein in serum and plasma...
    The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
    Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
    For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
    Medicine Products:
    (Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
    (Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
    (Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
    (Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
    (Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
    Breaking Medicine News(10 mins):
    (Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
    (Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
    (Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
    Breaking Medicine Technology: